The first question is not “does it work?”

The first question is what kind of use you are looking at. A prescription GLP-1 medicine, a collagen supplement, a hospital antibiotic, and an online research peptide should not be judged by the same shortcut.

1. Identify the product lane

Approved medicine: the strongest lane when the exact product and indication match the label. Examples include insulin, glucagon, semaglutide, leuprolide, octreotide, eptifibatide, icatibant, linaclotide, and many peptide antibiotics.

Diagnostic agent: the peptide is used to provoke a measurable response, such as adrenal, pancreatic, or growth-hormone-axis testing. The value is the test result, not ongoing self-treatment.

Cosmetic or supplement: the claim is usually appearance, nutrition, or support language. It is not the same as treating disease.

Research peptide: the product may have a proposed mechanism or animal data, but that is not the same as an approved human therapy.

2. Match the claim to the evidence

High-quality evidence is specific: this molecule, this formulation, this route, this dose form, this population, this outcome. Broad claims like “healing,” “longevity,” “anti-aging,” “recovery,” or “metabolic optimization” are weak unless they point to well-designed human data.

Mechanism-only claims can be seductive. A peptide may affect inflammation, appetite, hormone release, or cell signaling in a lab model while still having uncertain human benefit or safety.

3. Check the route

Route changes risk. A topical cosmetic peptide, an oral diagnostic product, a prescription injection pen, a hospital IV infusion, and a research-use vial are completely different safety situations.

Many peptides are degraded by digestion, which is why injectable or carefully engineered delivery systems are common for prescription products. This does not justify DIY injection. It makes product quality, sterility, concentration, labeling, and clinician oversight more important.

Use categories

These are the major buckets you will see in the catalog. The same word, peptide, covers very different levels of evidence and oversight.

Metabolic care

Insulin, glucagon, pramlintide, GLP-1 receptor agonists, and related incretin medicines affect glucose, appetite, gastric emptying, or hypoglycemia rescue. These are medical tools, not casual wellness products.

Reproductive and endocrine care

GnRH analogs, oxytocin analogs, vasopressin analogs, somatostatin analogs, and growth-hormone-axis products can strongly affect hormone systems. Specialist monitoring matters.

Bone, clotting, and rare disease

Peptide drugs can stimulate bone formation, affect platelets or thrombin, treat hereditary angioedema attacks, or support rare-disease care. These uses are diagnosis-specific.

Anti-infectives and oncology

Some peptide or peptide-like drugs are antibiotics, HIV entry inhibitors, or cancer medicines. These belong in infectious disease, hospital, or oncology care rather than peptide-therapy marketing.

Diagnostics

Cosyntropin, secretin, macimorelin, and related agents are used to test physiology. Timing, lab interpretation, medication holds, and clinical context determine usefulness.

Skin care

Topical peptides may support cosmetic claims around barrier feel, hydration, texture, or appearance. Formula quality matters more than the presence of a peptide name on the label.

Supplements

Collagen peptides are hydrolyzed protein fragments. They may have modest evidence for some skin or joint outcomes, but they are not prescription peptide drugs.

Research and wellness-market peptides

BPC-157, TB-500, CJC-1295, MOTS-c, Semax, Selank, KPV, DSIP, and similar products are often marketed ahead of human evidence. Research-use labeling should slow you down.

Route comparison

Route is one of the fastest ways to understand risk. It determines what quality controls, monitoring, and product design questions matter most.

Route	Where it appears	What to pay attention to
Subcutaneous injection	Insulin, GLP-1s, fertility medicines, osteoporosis medicines, some rare-disease medicines	Exact product, concentration, device, sterility, training, storage, monitoring, and side effects.
IV infusion	Hospital anti-infectives, anticoagulants, vasopressors, oncology drugs	Clinical setting, infusion monitoring, organ toxicity, compatibility, and acute adverse reactions.
Oral	Selected products such as linaclotide, plecanatide, oral semaglutide, macimorelin	Whether the molecule is designed for oral use; do not assume oral availability for other peptides.
Nasal	Some approved products and many unapproved wellness-market products	Device, dose delivery, mucosal absorption, irritation, and whether the product is approved or research-only.
Topical	Cosmetic peptides, some anti-infective products	Finished formula, skin irritation, stability, and avoiding medical claims that exceed cosmetic evidence.
Implant or pump	Hormone-suppression products, insulin pumps, specialist products	Placement, device management, duration, removal, and clinician follow-up.

Approved, compounded, or research-only?

Approved products have reviewed labeling for safety, effectiveness, quality, indications, contraindications, and warnings.

Compounded products can meet a legitimate medical need, but FDA says compounded drugs are not FDA-approved and do not receive premarket review for safety, effectiveness, or quality.

Research-only products should not be treated as patient-ready medicines. The label itself is a warning that the product may not be intended for human administration.

Evidence ladder

Strongest: approved product label for the exact use.
Useful: well-designed human trials for the same molecule, route, and outcome.
Preliminary: small studies, observational data, or indirect clinical experience.
Weakest: animal studies, cell studies, mechanism-only arguments, testimonials, and influencer protocols.

Red flags

Be cautious when a peptide is sold without a prescription, promoted with universal dosing, labeled research use only, advertised with before-and-after transformations, or bundled with claims about anti-aging, injury repair, fat loss, cognition, libido, and sleep all at once.

Also be cautious when the seller emphasizes purity percentages but provides no licensed pharmacy, no clear product identity, no sterile handling information, no adverse-event plan, and no clinician responsible for monitoring.

Questions that add value

Is this an approved medicine, a compounded medicine, a cosmetic, a supplement, or a research chemical?
What human evidence supports this exact product and use?
What route is being used, and what product-quality risks does that route introduce?
What side effects are common, and which symptoms are urgent?
Who is responsible for follow-up if something goes wrong?

Sources and next steps

FDA materials are especially useful for understanding compounded-drug risk, bulk-drug-substance rules, and why supplier quality matters. Clinical references are useful for approved drug classes such as GLP-1 receptor agonists. Dermatology sources are better for topical cosmetic peptides than peptide-vendor pages.

Use the catalog when you want peptide-specific details, and use the access page when you want safer sourcing and pharmacy questions.

How peptides are used